The onset of clinical symptoms in PRPH2-associated autosomal dominant Stargardt-like macular dystrophy was reported to start later in life (≥50 years old) [40], which could have allowed to distinguish them from the ABCA4 and ELOVL4 patients. Here, ELOVL4 is linked to Stargardt disease 3.